Equities

Comvita Ltd

Comvita Ltd

Actions
  • Price (USD)0.6828
  • Today's Change0.00 / 0.00%
  • Shares traded150.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jul 25 2024 14:37 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Comvita Limited is engaged in manufacturing and marketing nature health products, apiary ownership and native forest management. It is also involved in research, manufacturing and distributing manuka honey, bee products, and olive leaf products. It segments include Greater China, Australia, and New Zealand (ANZ), Rest of Asia, North America, and Europe, Middle East, and Africa (EMEA). Its product category includes Kids Health, Manuka Honey, Medihoney, Olive Leaf Extract, Oral Care, Propolis, Bundle Packs, Elixirs and Lozenges, and Gourmet Honey. Its products under Kids Health include Children's Manuka Honey Elixir, Kids Honey, and Kids Day-time Soother Bundle, and others. Its products under Manuka Honey include Manuka Lovers Luxury Pack, Manuka Blend Honey, and Manuka Blend Honey MGO, and others. Medihoney Wound Gel is its Medihoney product. Its Olive Leaf Extract products include Manuka Honey Lozenges Olive Leaf Extract and Manuka Honey Lozenges Olive Leaf Extract 12 Lozenges.

  • Revenue in NZD (TTM)225.43m
  • Net income in NZD3.70m
  • Incorporated1974
  • Employees559.00
  • Location
    Comvita LtdPrivate Bag 1TE PUKE 3153New ZealandNZL
  • Phone+64 75331426
  • Fax+64 75331118
  • Websitehttps://www.comvita.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.